Small Business Innovative Research Program Provides $175,000 in Funding for Chi Botanic's Sustainable Vanilla Technology

HanchorBio Received IND Clearance of HCB101 Multi-regional Clinical Trial By US FDA

Amplity Health's Remote Engagement Center Is Named J.D. Power Certified for Providing "An Outstanding Customer Service Experience"

New funding led by ICONIQ Growth brings total raised to $207 million and signals investor confidence in Apprentice's market-leading technology

The new website is part of Broad Institute's mission to support innovation and breakthroughs in the science and research community.

A new technology developed by BioMed X in collaboration with Janssen functionally identifies and validates T cell target antigens, making it a powerful tool for immunology discovery.

Interactome Bio Expands to Chicago's Portal Innovations

Pivotal acquisition in Envision Pharma Group's tech-enabled offerings provides clients with access to advanced AI to accelerate decision-making that optimizes their products' path to market and ultimately supports the delivery of enhanced patient outcomes.

In vitro antimicrobial resistance test enables clinical labs to deliver targeted therapeutic results days faster than the current standard of care, clearing the path for personalized antibiotic therapies

Aronora co-founder and CEO Dr. Erik Tucker has been elected as Fellow of the National Academy of Inventors (NAI)

ENTEXS's solventless Cold-Water Extraction technologies will premiere at the #1 global cannabis business conference and tradeshow, MJBIZCON, in Las Vegas today

Coming in overall at 125th, Apprentice is recognized for its 1,159% revenue growth as it continues to scale its Tempo Manufacturing Cloud platform for Life Sciences.

Dr. Lewis, PharmD, FIDSA, is one of the preeminent experts in antibiotic stewardship and susceptibility testing (AST). He brings a wealth of knowledge to Selux as the company transforms infectious diseases clinical care and preserves the lifesaving power of antibiotics with its Next Generation Phenotyping (NGP) platform.

German-based biotechnology company BioNTech will establish a clinical scale research mRNA manufacturing facility in Australia, following an in-principle letter of intent signed with the Victorian Government.

Produces nature-identical, animal-free dairy proteins for lower greenhouse gas emissions

Gb Sciences is focusing considerable resources on bringing its lead Parkinson's disease formulations to the clinic with promising results; plus, new data validating the efficacy of their novel anxiety formulations and demonstrating the improved stability of their oral nanoparticle-encapsulated chronic pain formulations add value to their drug development pipeline.

Acquisition allows Pace® to provide regulatory and quality consulting services to support clients throughout the drug development process and improve commercial compliance in FDA-regulated environments.

Signals firm's commitment to investing in biotech, biology, and computational 'super evolution' breakthroughs

Counteracts the impact of climate change and contributes to food security worldwide

ENTEXS' CBD Loss Rate of Less Than 5% Means Salus Bioceutical is First Manufacturer Able to Provide Premium Medical-Grade Extracts With Less Than 0.2% THC to Asian Market

Latest milestone brings the Selux Next-Generation Phenotyping (NGP) platform one step closer to impacting patient care with same-shift Antibiotic Susceptibility Testing (AST).

Todd Hood, PharmD, MHA, Bruce Valentine, and Tomas Andrade's appointments demonstrate Amplity's commitment to providing biopharmaceutical and device clients with a sophisticated approach to payer engagement.

Treatment in sight for over 25 million Americans after new clinical trial confirms safety and cognitive enhancement activity of low, once-a-day doses of Xanamem

Agribusiness consultants promoted to leadership team

Cobbs Creek Healthcare Expanding Into RWE/HEOR Area

Free, Virtual Symposium, April 25-26, 2022

Company Announces Appointment of Veteran Healthcare Communications Entrepreneur and Digital Analytics Expert, Anna Walz, to Board

Tailored service enables processing and QP release within 20 hours

Dan Cusack appointed to Principal, Market Access to support continued expansion of Market Access consulting capabilities

iMBP Teams with AWS

Turnkey research facility in The East Side neighborhood expands national network

Lipid inCode® offers greater diagnostic information for hypercholesterolemia sufferers over current NHS standard

A PNAS study demonstrates platelet-derived growth factor D (PDGF-D) binding to PDGF receptor-beta (PDGFRβ) activates NK cells to enhance interleukin (IL)-15-mediated NK cell survival.
City of Hope research suggests that the selective introduction of PDGF signaling in NK cells by IL-15 should benefit NK cell expansion and persistence and/or enhance effector function in NK cell-based immunotherapies.

Turnkey research facilities expand national network, opens new market

Commencement of regulatory pathway for U.S. market approval